Sustainable solutions that are beneficial to both the patient and planet

DSM Biomedical is a global leader in biomedical materials science – experience that we are now using to enable the formulation of advanced sustained release drug therapies as implantable or injectable delivery forms.

Our two proprietary, highly versatile polymer technologies serve as platforms for the development of long-acting formulations of bioactive ingredients, providing the potential for improved patient safety and therapy compliance when managing health conditions and lifelong diseases.

Biodegradable Polymer Platform

TheraPEA™, DSM Biomedical's novel biodegradable platform of Polyester Amide (PEA) polymers, enables the formulation of therapeutic solutions where they are needed most - in treatments of coronary artery disease, pain management, diabetes management, and for vision preservation. Our TheraPEA™ platform has proven compatibility with a wide range of active pharmaceutical ingredients and across different routes of administration to develop an optimal therapy for the patient.  

 The TheraPEA™ platform has a tunable degradation profile and offers many benefits over commonly used materials in this market, including:

  • Broad compatibility with a wide range of small molecule and biological drugs due to their non-acidic degradation and low susceptibility to acylation. 
  • Excellent biocompatibility, proven in multiple settings including ophthalmic, intravascular, and intra-articular applications.


Biostable (non-degradable) Polymer Platform

Our biomedical polyurethanes have a long successful clinical history and give formulators a proven, customizable platform from which to create delivery of medications for systemic drug delivery with duration of several days to multiple months.  DSM’s extensive polymer expertise allows customization of both the bulk and surface chemistries for targeted compositions based on the pharmaceutical attributes and hydrophilicity requirements.

Markets served by this technology

  • Cardiovascular


    DSM Biomedical materials and technologies support cardiovascular applications, including neurologic and peripheral vascular. Learn more.

  • Diabetes Management

    Diabetes Management

    DSM Biomedical materials and technologies support diabetes management and CGM applications.

  • Ophthalmology


    DSM Biomedical materials and technologies support ophthalmic, ophthalmology and drug delivery applications. Learn more.

  • Women's Health

    Women's Health

    DSM Biomedical materials and technologies support womens health, breast and gynecological applications. Learn more.

Aliphatic Thermoplastic​ Polyether Polyurethane ​product sheet​

Medical grade polymer with exceptional physical and biocompatibility properties​.

Bionate® PCU​ product sheet​

Recognized as an industry-leading medical grade polymer for long-term use in the body​.

CarboSil® TSPCU​ product sheet​

Ground-breaking copolymer that combines the benefits of silicone and polyurethane.

TheraPEA™ Biodegradable Polyester Amide Platform brochure

Read more

  • Our products

    Our products

    DSM portfolio of innovative biomedical materials and process manufacturing technologies: Biomedical Polyethylenes, Biomedical polyurethanes, Collagen Technology, Device Development, and Extracellular Matrix (ECM) Technology. Learn more.

  • The markets we serve

    The markets we serve

    DSM Biomedical offers the broadest portfolio of biomedical materials and manufacturing across market applications, including orthopedics, ophthalmology, neurology, cardiology, diabetes, wound, and continence care.

Want to get in touch?

We'd love to hear from you!

This site uses cookies to store information on your computer.

Learn more